Form 8-K - Current report:
SEC Accession No. 0001703057-23-000014
Filing Date
2023-06-20
Accepted
2023-06-20 16:56:41
Documents
12
Period of Report
2023-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20230615.htm   iXBRL 8-K 33428
  Complete submission text file 0001703057-23-000014.txt   155593

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20230615.xsd EX-101.SCH 1907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20230615_lab.xml EX-101.LAB 22785
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20230615_pre.xml EX-101.PRE 11962
6 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20230615_htm.xml XML 3923
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 231026016
SIC: 2834 Pharmaceutical Preparations